...
首页> 外文期刊>Drugs of the Future >EUROPEAN HEMATOLOGY ASSOCIATION -17~(TM) ANNUAL CONGRESS AMSTERDAM, THE NETHERLANDS - JUNE 14-17, 2012
【24h】

EUROPEAN HEMATOLOGY ASSOCIATION -17~(TM) ANNUAL CONGRESS AMSTERDAM, THE NETHERLANDS - JUNE 14-17, 2012

机译:欧洲血液学协会-17〜(TM)年度大会阿姆斯特丹,荷兰-2012年6月14日至17日

获取原文
获取原文并翻译 | 示例
           

摘要

The 17th Congress of the European Hematology Association was held in Amsterdam, the Netherlands, and was comprised of 18 educational and 56 scientific sessions, along with 1,005 posters. The congress attracted 9,201 attendees who came from top research centers and universities, as well as pharmaceutical and biotechnology companies. The aim of the meeting was to present the latest news on R&D of the origin and the treatment of blood-related diseases, and to promote excellence in clinical and practice research and education in hematology. The most popular topics of the conference were non-Hodgkin's lymphoma and multiple myeloma. This report reviews some of the new advances within the field, from new clinical results obtained from ongoing studies, to the description of novel therapeutic products in their initial stages of development.
机译:欧洲血液学协会第17届代表大会在荷兰阿姆斯特丹举行,由18场教育和56场科学会议以及1,005张海报组成。大会吸引了来自顶级研究中心和大学以及制药和生物技术公司的9,201名与会者。会议的目的是介绍有关血源性疾病的起源和治疗的最新研究消息,并促进血液学的临床和实践研究以及教育方面的卓越成就。会议上最受欢迎的主题是非霍奇金淋巴瘤和多发性骨髓瘤。本报告回顾了该领域的一些新进展,从正在进行的研究中获得的新临床结果,到对处于发展初期的新型治疗产品的描述。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号